5Indexed trials
drug · Product Intelligence
Lacosamide
Pipeline Intelligence
Lacosamide: 5 indexed trials, 4 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT00771927UCB Pharma · epilepsyCOMPLETED
NCT01673282UCB Pharma GmbH · epilepsyCOMPLETED
NCT01921205UCB Pharma · epilepsyPHASE3
NCT03436433Duke University · epilepsyPHASE2
NCT04737837Jiangxi Qingfeng Pharmaceutical Co. Ltd. · epilepsyUNKNOWN
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALLACOSAMIDE · 2025-06-26
FDA_APPROVALLACOSAMIDE · 2024-11-14
FDA_APPROVALLACOSAMIDE · 2024-05-15
FDA_APPROVALLACOSAMIDE · 2023-01-05
FDA_APPROVALLACOSAMIDE · 2022-08-26
FDA_APPROVALLACOSAMIDE · 2022-07-12
FDA_APPROVALLACOSAMIDE · 2022-04-07
FDA_APPROVALLACOSAMIDE · 2022-03-17
FDA_APPROVALLACOSAMIDE · 2022-03-17
FDA_APPROVALLACOSAMIDE · 2022-03-17
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.